CA 125 measurement in the follow-up of breast cancer patients.
During follow-up examinations for breast cancer the serum tumor marker CA 125 was measured routinely in the Universitätsfrauenklinik Erlangen. We found elevated CA 125 levels in 18 of 510 clinical asymptomatic patients. These patients were followed closely. A second malignant neoplasm was found in six of these patients, two at a curable early stage. We found metastases of breast cancer in nine patients and benign diseases in three patients.